What is the clinical significance of a serum creatinine of 1.40 mg/dL and how should it be evaluated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Significance of Serum Creatinine 1.40 mg/dL

A serum creatinine of 1.40 mg/dL requires immediate calculation of estimated GFR (eGFR) using validated equations, as this value alone is insufficient to determine renal function and may mask significant kidney disease, particularly in elderly patients, women, or those with reduced muscle mass.

Why Serum Creatinine Alone is Inadequate

Serum creatinine of 1.40 mg/dL falls within the traditional "normal" laboratory reference range for men (<1.5 mg/dL) but exceeds it for women (<1.4 mg/dL) 1. However, relying on this value alone is clinically dangerous because:

  • 40% of patients with decreased GFR have serum creatinine within normal laboratory ranges 1
  • The relationship between creatinine and GFR is hyperbolic—by the time creatinine rises significantly, GFR has already decreased by at least 40% 1
  • Creatinine production varies with muscle mass, age, sex, diet, and ethnicity 2

Mandatory Next Steps

Calculate eGFR immediately using the 2009 CKD-EPI equation (or 2012 CKD-EPI creatinine-cystatin C equation if available) 3. The MDRD equation is an acceptable alternative, but CKD-EPI is preferred 4, 3.

Critical Patient Factors That Affect Interpretation:

  • Age: A 75-year-old woman weighing 65 kg with creatinine 1.40 mg/dL may have GFR of only 40 mL/min, while a 30-year-old 90 kg male athlete with the same creatinine may have GFR of 110 mL/min 1
  • Sex: Women have lower muscle mass and creatinine production; 1.40 mg/dL is more concerning in women 1, 5
  • Muscle mass: Cachexia, sarcopenia, cirrhosis, and muscle-wasting diseases cause falsely low creatinine relative to actual GFR 2, 5, 6
  • Liver disease: Impaired hepatic creatine production in cirrhosis causes underestimation of kidney dysfunction 5

Risk Stratification Based on eGFR

Once eGFR is calculated, classify CKD stage 7, 3:

  • eGFR ≥90: Stage 1 (normal, but requires evidence of kidney damage)
  • eGFR 60-89: Stage 2 (mild decrease)
  • eGFR 30-59: Stage 3 (moderate decrease—requires nephrology evaluation)
  • eGFR 15-29: Stage 4 (severe decrease—prepare for renal replacement)
  • eGFR <15: Stage 5 (kidney failure)

Any eGFR <60 mL/min/1.73 m² for >3 months confirms CKD 7, 3.

Additional Evaluation Required

Beyond eGFR calculation, assess for:

  1. Proteinuria/albuminuria: Check urine albumin-to-creatinine ratio (preferred) or protein-to-creatinine ratio 3

    • Absence of proteinuria (>500 mg/day) and hematuria (>50 RBCs/hpf) helps distinguish functional from structural kidney injury 5
  2. Baseline comparison: Review creatinine values from previous 3 months 5

    • Acute increase of ≥0.3 mg/dL within 48 hours defines AKI 5
    • Increase to ≥1.5 times baseline within 7 days also defines AKI 5
  3. Nephrotoxin exposure: NSAIDs, contrast dye, antibiotics affecting tubular secretion 5

  4. Volume status: Dehydration, diuretic use, heart failure 2

  5. Renal ultrasound: If structural abnormality suspected 5

Prognostic Implications

Even "high-normal" creatinine values predict cardiovascular morbidity and mortality. In hypertensive patients, creatinine within reference range independently predicts cardiovascular events with excess risk of 1.30 (95% CI 1.07-1.59) for each 0.23 mg/dL increase 8. This persists after adjusting for blood pressure and left ventricular hypertrophy.

Common Pitfalls to Avoid

  • Never use serum creatinine alone without calculating eGFR 4, 7, 3
  • Do not assume "normal" lab range equals normal kidney function, especially in elderly, women, or low muscle mass patients 1, 9
  • In cirrhosis patients, creatinine underestimates kidney dysfunction; consider cystatin C-based eGFR 5, 6
  • In acute settings, recognize that creatinine lags behind actual GFR changes by 24-48 hours 5

When to Consider Cystatin C or Measured GFR

Use cystatin C-based eGFR or measured GFR (iothalamate/inulin clearance) when 3, 6:

  • eGFR 45-59 mL/min and confirmation of CKD needed
  • Extremes of muscle mass (cachexia, bodybuilders)
  • Cirrhosis or severe liver disease
  • Catabolic states (sepsis, malignancy, high-dose steroids)
  • Drug dosing decisions with narrow therapeutic index
  • Kidney donor evaluation

The bottom line: Creatinine 1.40 mg/dL demands immediate eGFR calculation and cannot be interpreted in isolation—it may represent normal function in a young muscular male or Stage 3 CKD in an elderly woman.

References

Guideline

meeting the challenges of the new k/doqi guidelines.

American Journal of Kidney Diseases, 2003

Research

Screening for renal disease using serum creatinine: who are we missing?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.